Evidence map›Paper›PMID 38811505›Full record

ArticleDigestive diseases and sciences2024

The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's Disease.

Jud C Janak, Anita M Loughlin, Page C Moore, Celeste A Lemay, Philip J Mease, Mark Lebwohl, Joshua R Korzenik, Raymond K Cross, David Hudesman

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jud C JanakCorEvitas LLC, Waltham, MA, USA.
Anita M LoughlinCorEvitas LLC, Waltham, MA, USA.
Page C MooreCorEvitas LLC, Waltham, MA, USA. pmoore@corevitas.com.
Celeste A LemayCorEvitas LLC, Waltham, MA, USA.
Philip J MeaseSwedish Medical Center/Providence St. Joseph Health, University of Washington School of Medicine, Seattle, WA, USA.
Mark LebwohlMount Sinai Hospital, New York, NY, USA.
Joshua R KorzenikBrigham and Women's Hospital, Boston, MA, USA.
Raymond K CrossUniversity of Maryland School of Medicine, Baltimore, MD, USA.
David HudesmanNYU Langone Health, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComparisons among autoimmune diseases enable understanding of the burden and factors associated with work productivity loss and impairment.

aimsThe objective was to compare work productivity and activity and associated factors among patients with inflammatory bowel diseases and other autoimmune conditions.

methodsThis cross-sectional study included employed, adult patients (age 20-64 years) in the CorEvitas Inflammatory Bowel Disease, Psoriasis, and Psoriatic Arthritis/Spondyloarthritis Registries between 5/2017 and 6/2020. Any patient-reported impairment on four domains of the Work Productivity and Activity Index (WPAI) was collected across registries. Prevalence for each autoimmune disease was reported and stratified by disease activity using direct age-sex-standardization. Factors associated with the presence of any WPAI were identified in logistic regression models.

resultsA total of 7,169 patients with psoriasis (n = 4,768, 67%), psoriatic arthritis (n = 1,208, 17%), Crohn's disease (CD, n = 621, 9%), and ulcerative colitis (UC, n = 572, 8%) met inclusion criteria. Among patients not in remission across all disease cohorts, the age-sex-standardized prevalence of any presenteeism, work productivity loss, and activity impairment ranged from 54 to 97%. Patients with CD in remission had higher standardized prevalence of presenteeism (53% [48-57%]) and work productivity loss (54% [49-59%]), compared to those from other cohorts (presenteeism [range: 33-39%] and work productivity loss [range: 37-41%]). For all WPAI domains, the strongest adjusted associations were for moderate to severe disease activity and psychosocial symptoms.

conclusionsPatients with moderate to severe disease activity reported the highest WPAI burden. However, patients in remission or mild disease activity also report some WPAI burden, emphasizing a multidisciplinary treatment approach to improve work productivity loss and impairment.

Indexed as

Colitis, UlcerativeCost of IllnessCrohn DiseaseEfficiencyPsoriasisAbsenteeismAdultArthritis, PsoriaticCross-Sectional StudiesFemaleHumansMaleMiddle AgedPresenteeismRegistriesYoung AdultCrohn’s DiseasePsoriasisPsoriatic ArthritisUlcerative ColitisWork Productivity and Activity Impairment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.